These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 17905588)

  • 1. Mono- and dialkyl isoprenoid bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.
    Wiemer AJ; Yu JS; Lamb KM; Hohl RJ; Wiemer DF
    Bioorg Med Chem; 2008 Jan; 16(1):390-9. PubMed ID: 17905588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pivaloyloxymethyl-modified isoprenoid bisphosphonates display enhanced inhibition of cellular geranylgeranylation.
    Wiemer AJ; Yu JS; Shull LW; Barney RJ; Wasko BM; Lamb KM; Hohl RJ; Wiemer DF
    Bioorg Med Chem; 2008 Apr; 16(7):3652-60. PubMed ID: 18308574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase.
    Wiemer AJ; Tong H; Swanson KM; Hohl RJ
    Biochem Biophys Res Commun; 2007 Feb; 353(4):921-5. PubMed ID: 17208200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of geranylgeranyl diphosphate synthase induces apoptosis through multiple mechanisms and displays synergy with inhibition of other isoprenoid biosynthetic enzymes.
    Dudakovic A; Wiemer AJ; Lamb KM; Vonnahme LA; Dietz SE; Hohl RJ
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1028-36. PubMed ID: 18083912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of a series of aromatic bisphosphonates.
    Barney RJ; Wasko BM; Dudakovic A; Hohl RJ; Wiemer DF
    Bioorg Med Chem; 2010 Oct; 18(20):7212-20. PubMed ID: 20832326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase.
    Bergstrom JD; Bostedor RG; Masarachia PJ; Reszka AA; Rodan G
    Arch Biochem Biophys; 2000 Jan; 373(1):231-41. PubMed ID: 10620343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
    Dunford JE; Thompson K; Coxon FP; Luckman SP; Hahn FM; Poulter CD; Ebetino FH; Rogers MJ
    J Pharmacol Exp Ther; 2001 Feb; 296(2):235-42. PubMed ID: 11160603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates induce autophagy by depleting geranylgeranyl diphosphate.
    Wasko BM; Dudakovic A; Hohl RJ
    J Pharmacol Exp Ther; 2011 May; 337(2):540-6. PubMed ID: 21335425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro studies in a myelogenous leukemia cell line suggest an organized binding of geranylgeranyl diphosphate synthase inhibitors.
    Reilly JE; Zhou X; Tong H; Kuder CH; Wiemer DF; Hohl RJ
    Biochem Pharmacol; 2015 Jul; 96(2):83-92. PubMed ID: 25952057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of fluorescently tagged isoprenoid bisphosphonates that inhibit protein geranylgeranylation.
    Maalouf MA; Wiemer AJ; Kuder CH; Hohl RJ; Wiemer DF
    Bioorg Med Chem; 2007 Mar; 15(5):1959-66. PubMed ID: 17254791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase Inhibitors.
    Haney SL; Wills VS; Wiemer DF; Holstein SA
    Molecules; 2017 May; 22(6):. PubMed ID: 28555000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphonocarboxylate inhibitors of Rab geranylgeranyl transferase disrupt the prenylation and membrane localization of Rab proteins in osteoclasts in vitro and in vivo.
    Coxon FP; Ebetino FH; Mules EH; Seabra MC; McKenna CE; Rogers MJ
    Bone; 2005 Sep; 37(3):349-58. PubMed ID: 16006204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geranylgeranyl diphosphate-based inhibitors of post-translational geranylgeranylation of cellular proteins.
    Macchia M; Jannitti N; Gervasi G; Danesi R
    J Med Chem; 1996 Mar; 39(7):1352-6. PubMed ID: 8691464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activity of isoprenoid bisphosphonates.
    Shull LW; Wiemer AJ; Hohl RJ; Wiemer DF
    Bioorg Med Chem; 2006 Jun; 14(12):4130-6. PubMed ID: 16517172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates.
    Ling Y; Li ZH; Miranda K; Oldfield E; Moreno SN
    J Biol Chem; 2007 Oct; 282(42):30804-16. PubMed ID: 17724033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geranylgeranyl diphosphate synthase: an emerging therapeutic target.
    Wiemer AJ; Wiemer DF; Hohl RJ
    Clin Pharmacol Ther; 2011 Dec; 90(6):804-12. PubMed ID: 22048229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of action of bisphosphonates: current status.
    Roelofs AJ; Thompson K; Gordon S; Rogers MJ
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6222s-6230s. PubMed ID: 17062705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bishomoisoprenoid triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase.
    Wills VS; Metzger JI; Allen C; Varney ML; Wiemer DF; Holstein SA
    Bioorg Med Chem; 2017 Apr; 25(8):2437-2444. PubMed ID: 28302510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biochemical, and cellular evaluation of farnesyl monophosphate prodrugs as farnesyltransferase inhibitors.
    Clark MK; Scott SA; Wojtkowiak J; Chirco R; Mathieu P; Reiners JJ; Mattingly RR; Borch RF; Gibbs RA
    J Med Chem; 2007 Jul; 50(14):3274-82. PubMed ID: 17555307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a bisphosphonate that inhibits isopentenyl diphosphate isomerase and farnesyl diphosphate synthase.
    Thompson K; Dunford JE; Ebetino FH; Rogers MJ
    Biochem Biophys Res Commun; 2002 Jan; 290(2):869-73. PubMed ID: 11785983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.